Patentable/Patents/US-11465113
US-11465113

Use of a reactor, methods, and device for quantitatively obtaining molecular hydrogen from substances

PublishedOctober 11, 2022
Assigneenot available in USPTO data we have
Inventorsnot available in USPTO data we have
Technical Abstract

The invention relates to the use of a reactor, methods, and devices for the quantitative recovery of molecular hydrogen from solid, liquid, or gaseous substances which contain hydrogen and which have heteroatoms, as well as to reactors. In this case, the reactors have material containing chromium. The subject matter of the invention also includes the use of the reactor, the method, and the device for the compound-specific or component-specific measurement of the isotope ratio (δ2H) of hydrogen using online apparatuses.

Patent Claims

Legal claims defining the scope of protection. Each claim is shown in both the original legal language and a plain English translation.

Claims not yet imported for this patent.

Claims are being imported from USPTO data. Check back soon!

Classification Codes (CPC)

Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.

Patent Metadata

Filing Date

February 11, 2016

Publication Date

October 11, 2022

Want to explore more patents?

Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.

Citation & reuse

Analysis on this page is generated by Patentable — an AI-powered patent intelligence platform. AI-generated summaries, explanations, FAQs, and analysis may be reused with attribution and a visible link back to the canonical URL below. Patent abstracts and claims are USPTO public domain.

Cite as: Patentable. “Use of a reactor, methods, and device for quantitatively obtaining molecular hydrogen from substances” (US-11465113). https://patentable.app/patents/US-11465113

© 2026 Nomic Interactive Technology LLC. Machine-readable context available at /api/llm-context/US-11465113. See llms.txt for full attribution policy.